ImpriMed, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
ImpriMed, Inc. is a biotechnology company based in Palo Alto, California, founded in 2017 in Silicon Valley. It develops precision medicine for cancer by applying artificial intelligence to predict cancer drug responses. Its current focus is veterinary oncology, providing tests to guide treatment for canine and feline blood cancers, with more than 22,000 tests conducted across the United States and deployment in over 40 states. The company has a small to mid-sized team. In 2025, ImpriMed expanded its facilities to Palo Alto, California.